A novel optimal feature selection technique for medical data classification using ANOVA based whale optimization

Author(s):  
Usha Moorthy ◽  
Usha Devi Gandhi
2016 ◽  
Vol 76 (22) ◽  
pp. 24457-24475 ◽  
Author(s):  
Vijay Bhaskar Semwal ◽  
Joyeeta Singha ◽  
Pinki Kumari Sharma ◽  
Arun Chauhan ◽  
Basudeba Behera

Author(s):  
Vinod Jagannath Kadam ◽  
Shivajirao Manikrao Jadhav

Medical data classification is the process of transforming descriptions of medical diagnoses and procedures into universal medical code numbers. The diagnoses and procedures are usually taken from a variety of sources within the healthcare record, such as the transcription of the physician’s notes, laboratory results, radiologic results and other sources. However, there exist many frequency distribution problems in these domains. Hence, this paper intends to develop an advanced and precise medical data classification approach for diabetes and breast cancer dataset. With the knowledge of the features and challenges persisting with the state-of-the-art classification methods, deep learning-based medical data classification methodology is proposed here. It is well known that deep learning networks learn directly from the data. In this paper, the medical data is dimensionally reduced using Principle Component Analysis (PCA). The dimensionally reduced data are transformed by multiplying by a weighting factor, which is optimized using Whale Optimization Algorithm (WOA), to obtain the maximum distance between the features. As a result, the data are transformed into a label-distinguishable plane under which the Deep Belief Network (DBN) is adopted to perform the deep learning process, and the data classification is performed. Further, the proposed WOA-based DBN (WOADBN) method is compared with the Neural Network (NN), DBN, Generic Algorithm-based NN (GANN), GADBN, Particle Swarm Optimization (PSONN), PSO-based DBN (PSODBN), WOA-based NN (WOANN) techniques and the results are obtained, which shows the superiority of proposed algorithm over conventional methods.


2015 ◽  
Vol 5 (5) ◽  
pp. 1093-1098
Author(s):  
Simon Fong ◽  
Justin Liang ◽  
Shirley W. I. Siu ◽  
Jonathan H. Chan

2021 ◽  
Vol 16 ◽  
Author(s):  
Dan Lin ◽  
Jialin Yu ◽  
Ju Zhang ◽  
Huan He ◽  
Xinyun Guo ◽  
...  

Background: Anti-inflammatory peptides (AIPs) are potent therapeutic agents for inflammatory and autoimmune disorders due to their high specificity and minimal toxicity under normal conditions. Therefore, it is greatly significant and beneficial to identify AIPs for further discovering novel and efficient AIPs-based therapeutics. Recently, three computational approaches, which can effectively identify potential AIPs, have been developed based on machine learning algorithms. However, there are several challenges with the existing three predictors. Objective: A novel machine learning algorithm needs to be proposed to improve the AIPs prediction accuracy. Methods: This study attempts to improve the recognition of AIPs by employing multiple primary sequence-based feature descriptors and an efficient feature selection strategy. By sorting features through four enhanced minimal redundancy maximal relevance (emRMR) methods, and then attaching seven different classifiers wrapper methods based on the sequential forward selection algorithm (SFS), we proposed a hybrid feature selection technique emRMR-SFS to optimize feature vectors. Furthermore, by evaluating seven classifiers trained with the optimal feature subset, we developed the extremely randomized tree (ERT) based predictor named PREDAIP for identifying AIPs. Results: We systematically compared the performance of PREDAIP with the existing tools on an independent test dataset. It demonstrates the effectiveness and power of the PREDAIP. The correlation criteria used in emRMR would affect the selection results of the optimal feature subset at the SFS-wrapper stage, which justifies the necessity for considering different correlation criteria in emRMR. Conclusion: We expect that PREDAIP will be useful for the high-throughput prediction of AIPs and the development of AIPs therapeutics.


Sign in / Sign up

Export Citation Format

Share Document